New

Naloxone Hydrochloride Market

2021

Naloxone Hydrochloride Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type ( More than 98%, Less than 98% ); Application ( Injection, Tablets, Others ), and geography

| Report Code: TIPRE00020855 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Naloxone Hydrochloride Market 2028 By Type, Application, and geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Naloxone hydrochloride is the hydrochloride salt of naloxone, a thebaine derivate with antagonistic role of opioids. Naloxone binds to opioid receptors in the Central Nervous System in a competitive manner, reversing or inhibiting characteristic opioid effects, including euphoria, analgesia, sedation, respiratory depression, bradycardia, miosis, and physical dependence. This agent binds to mu-opioid receptors with a high affinity and a lesser degree to kappa- and gamma-opioid receptors. Naloxone can be used to reverse opioid depression entirely or partially, including moderate to extreme respiratory depression caused by natural and synthetic opioids, the agonists/antagonists nalbuphine and pentazocine, or dextropropoxyphene. It may also be used for the diagnosis of suspected acute opioid overdosage. Naloxone may be used to counteract respiratory and other CNS depression in the newborn resulting from the administration of analgesics to the mother during childbirth.

MARKET DYNAMICS

Factors driving the growth of the naloxone hydrochloride market are the growing prevalence of opioid overdose, coupled with rising number of victims with dependency on opioid. However, the high cost of and side effects of naloxone hydrochloride is expected to hamper the growth of the market. Moreover, growing dependency on opioids and rising investments by major market players in naloxone hydrochloride is anticipated to boost the market growth.

MARKET SCOPE

The "Naloxone Hydrochloride Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of naloxone hydrochloride market with detailed market segmentation by type and application. The naloxone hydrochloride market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in naloxone hydrochloride market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The naloxone hydrochloride market is segmented on the basis of type and application. Based on type, the market is segmented as More than 98% and Less than 98%. On the basis of application, the market is categorized as injection, tablets, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the naloxone hydrochloride market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The naloxone hydrochloride market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting naloxone hydrochloride market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the naloxone hydrochloride market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the naloxone hydrochloride market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from naloxone hydrochloride market are anticipated to have lucrative growth opportunities in the future with the rising demand for naloxone hydrochloride in the global market. Below mentioned is the list of few companies engaged in the naloxone hydrochloride market.

The report also includes the profiles of key players in naloxone hydrochloride market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Sun Pharmaceutical
  •   Siegfried
  •   VAV Life Sciences
  •   Xinhua Pharm
  •   YaoPharma
  •   Gaobo Jingband Pharmaceutical
  •   PUAN Pharmaceutical
  •   Aoxing Group Pharmaceutical
  •   Teva Pharmaceutical
  •   Nhwa Pharmaceutical
  •   Easton Biopharmaceuticals
  •   Noramco
  •   Mallinckrodt Plc
  •   Temad Co
  •   Johnson Matthey PLC
  •   Faran Shimi Pharmaceutical Company
  •   Micro Orgo Chem
  •   Resonance Laboratories Pvt. Ltd
  •   Rusan Pharma
  •   Siegfried AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Naloxone Hydrochloride Market - By Type
1.3.2 Naloxone Hydrochloride Market - By Application
1.3.3 Naloxone Hydrochloride Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NALOXONE HYDROCHLORIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NALOXONE HYDROCHLORIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NALOXONE HYDROCHLORIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. NALOXONE HYDROCHLORIDE - GLOBAL MARKET OVERVIEW
6.2. NALOXONE HYDROCHLORIDE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NALOXONE HYDROCHLORIDE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MORE THAN 98%
7.3.1. Overview
7.3.2. More than 98% Market Forecast and Analysis
7.4. LESS THAN 98%
7.4.1. Overview
7.4.2. Less than 98% Market Forecast and Analysis
8. NALOXONE HYDROCHLORIDE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. INJECTION
8.3.1. Overview
8.3.2. Injection Market Forecast and Analysis
8.4. TABLETS
8.4.1. Overview
8.4.2. Tablets Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. NALOXONE HYDROCHLORIDE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Naloxone Hydrochloride Market Overview
9.1.2 North America Naloxone Hydrochloride Market Forecasts and Analysis
9.1.3 North America Naloxone Hydrochloride Market Forecasts and Analysis - By Type
9.1.4 North America Naloxone Hydrochloride Market Forecasts and Analysis - By Application
9.1.5 North America Naloxone Hydrochloride Market Forecasts and Analysis - By Countries
9.1.5.1 United States Naloxone Hydrochloride Market
9.1.5.1.1 United States Naloxone Hydrochloride Market by Type
9.1.5.1.2 United States Naloxone Hydrochloride Market by Application
9.1.5.2 Canada Naloxone Hydrochloride Market
9.1.5.2.1 Canada Naloxone Hydrochloride Market by Type
9.1.5.2.2 Canada Naloxone Hydrochloride Market by Application
9.1.5.3 Mexico Naloxone Hydrochloride Market
9.1.5.3.1 Mexico Naloxone Hydrochloride Market by Type
9.1.5.3.2 Mexico Naloxone Hydrochloride Market by Application
9.2. EUROPE
9.2.1 Europe Naloxone Hydrochloride Market Overview
9.2.2 Europe Naloxone Hydrochloride Market Forecasts and Analysis
9.2.3 Europe Naloxone Hydrochloride Market Forecasts and Analysis - By Type
9.2.4 Europe Naloxone Hydrochloride Market Forecasts and Analysis - By Application
9.2.5 Europe Naloxone Hydrochloride Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Naloxone Hydrochloride Market
9.2.5.1.1 Germany Naloxone Hydrochloride Market by Type
9.2.5.1.2 Germany Naloxone Hydrochloride Market by Application
9.2.5.2 France Naloxone Hydrochloride Market
9.2.5.2.1 France Naloxone Hydrochloride Market by Type
9.2.5.2.2 France Naloxone Hydrochloride Market by Application
9.2.5.3 Italy Naloxone Hydrochloride Market
9.2.5.3.1 Italy Naloxone Hydrochloride Market by Type
9.2.5.3.2 Italy Naloxone Hydrochloride Market by Application
9.2.5.4 Spain Naloxone Hydrochloride Market
9.2.5.4.1 Spain Naloxone Hydrochloride Market by Type
9.2.5.4.2 Spain Naloxone Hydrochloride Market by Application
9.2.5.5 United Kingdom Naloxone Hydrochloride Market
9.2.5.5.1 United Kingdom Naloxone Hydrochloride Market by Type
9.2.5.5.2 United Kingdom Naloxone Hydrochloride Market by Application
9.2.5.6 Rest of Europe Naloxone Hydrochloride Market
9.2.5.6.1 Rest of Europe Naloxone Hydrochloride Market by Type
9.2.5.6.2 Rest of Europe Naloxone Hydrochloride Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Naloxone Hydrochloride Market Overview
9.3.2 Asia-Pacific Naloxone Hydrochloride Market Forecasts and Analysis
9.3.3 Asia-Pacific Naloxone Hydrochloride Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Naloxone Hydrochloride Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Naloxone Hydrochloride Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Naloxone Hydrochloride Market
9.3.5.1.1 Australia Naloxone Hydrochloride Market by Type
9.3.5.1.2 Australia Naloxone Hydrochloride Market by Application
9.3.5.2 China Naloxone Hydrochloride Market
9.3.5.2.1 China Naloxone Hydrochloride Market by Type
9.3.5.2.2 China Naloxone Hydrochloride Market by Application
9.3.5.3 India Naloxone Hydrochloride Market
9.3.5.3.1 India Naloxone Hydrochloride Market by Type
9.3.5.3.2 India Naloxone Hydrochloride Market by Application
9.3.5.4 Japan Naloxone Hydrochloride Market
9.3.5.4.1 Japan Naloxone Hydrochloride Market by Type
9.3.5.4.2 Japan Naloxone Hydrochloride Market by Application
9.3.5.5 South Korea Naloxone Hydrochloride Market
9.3.5.5.1 South Korea Naloxone Hydrochloride Market by Type
9.3.5.5.2 South Korea Naloxone Hydrochloride Market by Application
9.3.5.6 Rest of Asia-Pacific Naloxone Hydrochloride Market
9.3.5.6.1 Rest of Asia-Pacific Naloxone Hydrochloride Market by Type
9.3.5.6.2 Rest of Asia-Pacific Naloxone Hydrochloride Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Naloxone Hydrochloride Market Overview
9.4.2 Middle East and Africa Naloxone Hydrochloride Market Forecasts and Analysis
9.4.3 Middle East and Africa Naloxone Hydrochloride Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Naloxone Hydrochloride Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Naloxone Hydrochloride Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Naloxone Hydrochloride Market
9.4.5.1.1 South Africa Naloxone Hydrochloride Market by Type
9.4.5.1.2 South Africa Naloxone Hydrochloride Market by Application
9.4.5.2 Saudi Arabia Naloxone Hydrochloride Market
9.4.5.2.1 Saudi Arabia Naloxone Hydrochloride Market by Type
9.4.5.2.2 Saudi Arabia Naloxone Hydrochloride Market by Application
9.4.5.3 U.A.E Naloxone Hydrochloride Market
9.4.5.3.1 U.A.E Naloxone Hydrochloride Market by Type
9.4.5.3.2 U.A.E Naloxone Hydrochloride Market by Application
9.4.5.4 Iran Naloxone Hydrochloride Market
9.4.5.4.1 Iran Naloxone Hydrochloride Market by Type
9.4.5.4.2 Iran Naloxone Hydrochloride Market by Application
9.4.5.5 Rest of Middle East and Africa Naloxone Hydrochloride Market
9.4.5.5.1 Rest of Middle East and Africa Naloxone Hydrochloride Market by Type
9.4.5.5.2 Rest of Middle East and Africa Naloxone Hydrochloride Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Naloxone Hydrochloride Market Overview
9.5.2 South and Central America Naloxone Hydrochloride Market Forecasts and Analysis
9.5.3 South and Central America Naloxone Hydrochloride Market Forecasts and Analysis - By Type
9.5.4 South and Central America Naloxone Hydrochloride Market Forecasts and Analysis - By Application
9.5.5 South and Central America Naloxone Hydrochloride Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Naloxone Hydrochloride Market
9.5.5.1.1 Brazil Naloxone Hydrochloride Market by Type
9.5.5.1.2 Brazil Naloxone Hydrochloride Market by Application
9.5.5.2 Argentina Naloxone Hydrochloride Market
9.5.5.2.1 Argentina Naloxone Hydrochloride Market by Type
9.5.5.2.2 Argentina Naloxone Hydrochloride Market by Application
9.5.5.3 Rest of South and Central America Naloxone Hydrochloride Market
9.5.5.3.1 Rest of South and Central America Naloxone Hydrochloride Market by Type
9.5.5.3.2 Rest of South and Central America Naloxone Hydrochloride Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NALOXONE HYDROCHLORIDE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NALOXONE HYDROCHLORIDE MARKET, KEY COMPANY PROFILES
12.1. SUN PHARMACEUTICAL
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SIEGFRIED
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. VAV LIFE SCIENCES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. XINHUA PHARM
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. YAOPHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GAOBO JINGBAND PHARMACEUTICAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PUAN PHARMACEUTICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AOXING GROUP PHARMACEUTICAL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA PHARMACEUTICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NHWA PHARMACEUTICAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. EASTON BIOPHARMACEUTICALS
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
12.12. NORAMCO
12.12.1. Key Facts
12.12.2. Business Description
12.12.3. Products and Services
12.12.4. Financial Overview
12.12.5. SWOT Analysis
12.12.6. Key Developments
12.13. MALLINCKRODT PLC
12.13.1. Key Facts
12.13.2. Business Description
12.13.3. Products and Services
12.13.4. Financial Overview
12.13.5. SWOT Analysis
12.13.6. Key Developments
12.14. TEMAD CO
12.14.1. Key Facts
12.14.2. Business Description
12.14.3. Products and Services
12.14.4. Financial Overview
12.14.5. SWOT Analysis
12.14.6. Key Developments
12.15. JOHNSON MATTHEY PLC
12.15.1. Key Facts
12.15.2. Business Description
12.15.3. Products and Services
12.15.4. Financial Overview
12.15.5. SWOT Analysis
12.15.6. Key Developments
12.16. FARAN SHIMI PHARMACEUTICAL COMPANY
12.16.1. Key Facts
12.16.2. Business Description
12.16.3. Products and Services
12.16.4. Financial Overview
12.16.5. SWOT Analysis
12.16.6. Key Developments
12.17. MICRO ORGO CHEM
12.17.1. Key Facts
12.17.2. Business Description
12.17.3. Products and Services
12.17.4. Financial Overview
12.17.5. SWOT Analysis
12.17.6. Key Developments
12.18. RESONANCE LABORATORIES PVT. LTD
12.18.1. Key Facts
12.18.2. Business Description
12.18.3. Products and Services
12.18.4. Financial Overview
12.18.5. SWOT Analysis
12.18.6. Key Developments
12.19. RUSAN PHARMA
12.19.1. Key Facts
12.19.2. Business Description
12.19.3. Products and Services
12.19.4. Financial Overview
12.19.5. SWOT Analysis
12.19.6. Key Developments
12.20. SIEGFRIED AG
12.20.1. Key Facts
12.20.2. Business Description
12.20.3. Products and Services
12.20.4. Financial Overview
12.20.5. SWOT Analysis
12.20.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Sun Pharmaceutical
2. Siegfried
3. VAV Life Sciences
4. Xinhua Pharm
5. YaoPharma
6. Gaobo Jingband Pharmaceutical
7. PUAN Pharmaceutical
8. Aoxing Group Pharmaceutical
9. Teva Pharmaceutical
10. Nhwa Pharmaceutical
11. Easton Biopharmaceuticals
12. Noramco
13. Mallinckrodt Plc
14. Temad Co
15. Johnson Matthey PLC
16. Faran Shimi Pharmaceutical Company
17. Micro Orgo Chem
18. Resonance Laboratories Pvt. Ltd
19. Rusan Pharma
20. Siegfried AG
TIPRE00020855
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.